J&J, BMS lose challenges to US drug price negotiation program

Reuters

29 April 2024 - A US judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the US Government's Medicare health insurance program or pay heavy penalties.

US District Judge Zahid Quraishi in Trenton, New Jersey, became the fourth federal judge, opens new tab to uphold the program, one of Democratic President Joe Biden's signature initiatives, against drug industry challenges, rejecting their argument that it was an illegal taking of their property.

Read Reuters article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing